SIEMENS brand ARTISTE syngo RT Therapist (RTT) version 4.3, ARTISTE Model, Part No. 08162815, Dig...

FDA Device Recall #Z-0907-2013 — Class II — January 17, 2013

Recall Summary

Recall Number Z-0907-2013
Classification Class II — Moderate risk
Date Initiated January 17, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Siemens Medical Solutions USA, Inc
Location Concord, CA
Product Type Devices
Quantity 5 units

Product Description

SIEMENS brand ARTISTE syngo RT Therapist (RTT) version 4.3, ARTISTE Model, Part No. 08162815, Digital linear accelerators, MOSAIQ OIS system, Distributed by SIEMENS Healthcare IM CR RO, CR Radiation Oncology, Manufactured by SIEMENS AG, MEDICAL SOLUTIONS, GERMANY.

Reason for Recall

Siemens became aware of a potential safety issue when using the "In-session resumption" feature of the syngo RT Therapist (RTT) 4.3 software. The RTT will send again the previously completed beam or segment for delivery to the control console, thus repeating the already delivered Monitor Units of the same beam or segment.

Distribution Pattern

5 devices, all located outside of the United States in Germany.

Lot / Code Information

All codes/units of ARTISTE model.

Other Recalls from Siemens Medical Solutions USA, Inc

Recall # Classification Product Date
Z-0786-2014 Class II SIMVIEW NT and SIMVIEW NT with IDI: October ... Dec 11, 2013
Z-0787-2014 Class II PRIMUS, ONCOR, ARTISTE Linac systems with compo... Dec 5, 2013
Z-0437-2014 Class II SIEMENS brand ONCOR series Linear Accelerator L... Oct 23, 2013
Z-0438-2014 Class II SIEMENS brand ARTISTE Linear Accelerator Linac ... Oct 23, 2013
Z-2095-2013 Class II PRIMUS, ONCOR, ARTISTE Linac systems with compo... Jul 18, 2013

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.